These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1751781)

  • 1. Recombinant antibodies.
    Larrick JW; Fry KE
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):172-89. PubMed ID: 1751781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of genetically engineered monoclonal antibodies for human immunotherapy.
    Parren PW
    Hum Antibodies Hybridomas; 1992 Jul; 3(3):137-45. PubMed ID: 1391663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
    Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
    J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Production of antibodies with the aid of genetic technology].
    Hammarström L; Smith E
    Nord Med; 1990; 105(1):13-5, 23. PubMed ID: 2300434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.
    Okamoto T; Mukai Y; Yoshioka Y; Shibata H; Kawamura M; Yamamoto Y; Nakagawa S; Kamada H; Hayakawa T; Mayumi T; Tsutsumi Y
    Biochem Biophys Res Commun; 2004 Oct; 323(2):583-91. PubMed ID: 15369791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific human antibodies from mice comprising four distinct genetic modifications.
    Lonberg N; Taylor LD; Harding FA; Trounstine M; Higgins KM; Schramm SR; Kuo CC; Mashayekh R; Wymore K; McCabe JG
    Nature; 1994 Apr; 368(6474):856-9. PubMed ID: 8159246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.
    Chin LT; Chu C; Chen HM; Hsu SC; Weng BC; Chu CH
    BMC Biotechnol; 2007 Aug; 7():51. PubMed ID: 17714596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designer genes: recombinant antibody fragments for biological imaging.
    Wu AM; Yazaki PJ
    Q J Nucl Med; 2000 Sep; 44(3):268-83. PubMed ID: 11105590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangement of only one human IGHV gene is sufficient to generate a wide repertoire of antigen specific antibody responses in transgenic mice.
    Suárez E; Magadán S; Sanjuán I; Valladares M; Molina A; Gambón F; Díaz-Espada F; González-Fernández A
    Mol Immunol; 2006 Apr; 43(11):1827-35. PubMed ID: 16343622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen.
    Maeda F; Nagatsuka Y; Ihara S; Aotsuka S; Ono Y; Inoko H; Takekoshi M
    J Med Virol; 1999 Aug; 58(4):338-45. PubMed ID: 10421399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
    Wu SC; Lin YJ; Chou JW; Lin CW
    Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant anti-Rh(D) monoclonal antibodies: improvement of biological properties by in vitro class-switch.
    Klein P; Béliard R; Glacet A; Moitel S; Ducrot T; Bourel D
    Hum Antibodies; 1997; 8(1):17-25. PubMed ID: 9265501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of phage libraries for the in vitro production of recombinant monoclonal antibodies of predetermined specificity].
    Flego M; Ascione A; Pini A; Mennella V; Dupuis ML; Benagiano G; Cianfriglia M
    Ann Ist Super Sanita; 2002; 38(4):401-10. PubMed ID: 12760337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody engineering: an overview.
    O'Kennedy R; Roben P
    Essays Biochem; 1991; 26():59-75. PubMed ID: 1778186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant antibodies: alternative strategies for developing and manipulating murine-derived monoclonal antibodies.
    Peterson NC
    Lab Anim Sci; 1996 Feb; 46(1):8-14. PubMed ID: 8699826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.